Affiliation:
1. Washington State University, Spokane, WA, USA
Abstract
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.
Subject
Pharmacology (medical),Pharmacology,Pharmacy
Reference37 articles.
1. Jesduvroq (daprodustat). Prescribing information. GlaxoSmithKline; February 2023.
2. Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
3. Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
4. Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis
5. AstraZeneca. Update on US regulatory review of roxadustat in anaemia of chronic kidney disease [news release]. Published August 11, 2021. Accessed February 20, 2023. https://www.astrazeneca.com/media-centre/press-releases/2021/update-on-us-review-of-roxadustat.html